CN111249404A - Powder and preparation method thereof - Google Patents
Powder and preparation method thereof Download PDFInfo
- Publication number
- CN111249404A CN111249404A CN202010239209.9A CN202010239209A CN111249404A CN 111249404 A CN111249404 A CN 111249404A CN 202010239209 A CN202010239209 A CN 202010239209A CN 111249404 A CN111249404 A CN 111249404A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- herb
- raw materials
- baking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a powder which comprises the following raw materials in parts by weight: 23-33 parts of galium aparine, 25-35 parts of plantain herb, 30-49 parts of houttuynia cordata, 15-23 parts of arthroncus, 20-33 parts of Chinese forest frog grass, 7-15 parts of liquorice, 22-35 parts of scutellaria baicalensis, 11-17 parts of almond, 17-23 parts of fritillaria cirrhosa, 16-23 parts of radix bupleuri, 17-25 parts of mint, 26-33 parts of dandelion and 20-30 parts of lalang grass rhizome. The Chinese medicinal composition has the main effects of clearing heat and removing toxicity, protecting the liver, moistening the lung, relieving cough and improving the immunity of a human body, resists the invasion of various inflammations and viral colds from the human body, overcomes the defect of western medicines for treating colds, avoids damaging other internal organs, is convenient and safe to use, has small toxic or side effect, does not have adverse reaction, and has low cost and quick response.
Description
Technical Field
The invention relates to the field of medical supplies, in particular to powder and a preparation method thereof.
Background
The average date of suffering from cold or flu per year in China is about 18.5 days, the total cost for treating the cold per year is an astronomical number, and the time delay, the vehicle cost and the like for treating the cold cannot be estimated; at present, the treatment of cold through western medicine is mainly intravenous drip, mainly takes sterilization and inflammation diminishing as main purposes, kills pathogenic bacteria in vivo through blood circulation, but cannot help the body to generate antibodies, always causes repeated diseases, and has certain damage to internal organs.
Disclosure of Invention
The invention aims to overcome the problems in the prior art, and provides the powder which mainly has the functions of clearing away heat and toxic materials, protecting the liver, moistening the lung, relieving cough and improving the immunity of a human body, resists the invasion of various inflammations and viral colds from the human body, overcomes the defect that western medicines treat colds, avoids damaging other internal organs, is convenient and safe to use, has small toxic and side effects, only causes discomfort, is easy to cause dry throat and only needs to drink more boiled water; the invention has low cost, quick effect and easy wide popularization.
In order to achieve the above object, the present invention employs the following:
the powder comprises the following raw materials in parts by weight: 23-33 parts of galium aparine, 25-35 parts of plantain, 30-49 parts of houttuynia cordata, 15-23 parts of arthroncus, 20-33 parts of Chinese forest frog grass, 7-15 parts of liquorice, 22-35 parts of scutellaria baicalensis, 11-17 parts of almonds, 17-23 parts of fritillaria cirrhosa, 16-23 parts of radix bupleuri, 17-25 parts of mint and 26-33 parts of dandelion
And 20-30 parts of cogongrass rhizome.
Preferably, 30 parts of galium aparine, 30 parts of plantain, 40 parts of cordate houttuynia, 20 parts of arthroncus, 30 parts of Chinese forest frog, 10 parts of liquorice, 30 parts of scutellaria baicalensis, 15 parts of almond, 20 parts of fritillaria cirrhosa, 20 parts of radix bupleuri, 20 parts of mint, 30 parts of dandelion and 25 parts of lalang grass rhizome.
Preferably, 23 parts of galium aparine, 25 parts of plantain, 30 parts of cordate houttuynia, 15 parts of arthroncus, 20 parts of Chinese forest frog, 7 parts of liquorice, 22 parts of scutellaria baicalensis, 11 parts of almond, 17 parts of fritillaria cirrhosa, 16 parts of radix bupleuri, 17 parts of mint, 26 parts of dandelion and 20 parts of lalang grass rhizome.
Preferably, 33 parts of galium aparine, 35 parts of plantain herb, 49 parts of cordate houttuynia, 23 parts of arthroncus, 33 parts of Chinese forest frog grass, 15 parts of liquorice, 35 parts of scutellaria baicalensis, 17 parts of almond, 23 parts of fritillaria cirrhosa, 23 parts of radix bupleuri, 25 parts of mint, 33 parts of dandelion and 30 parts of lalang grass rhizome.
A preparation method of powder comprises the following steps:
step one, cleaning raw materials: cleaning the above raw materials;
step two, drying and baking: putting the prepared raw materials in the first step into a far infrared oven for drying and baking, wherein the baking time is 6-7 hours, and the baking temperature is 50-60 ℃;
step three, crushing: crushing the raw materials baked and dried in the second step by using a crusher respectively;
step four, pulverizing: weighing the powder prepared in the third step according to the weight proportion, and putting the powder into a stirrer to be uniformly stirred;
step five, packaging and bagging: and (4) packaging the mixed powder stirred and blended in the step four into bags, wherein each packaging paper bag is thin kraft paper containing tin, the weight of each bag is 300-500 g, and an electric sealing machine is used for packaging.
Preferably, in the second step, the baking time is 6 hours, and the baking temperature is 60 ℃.
Preferably, in the second step, the baking time is 7 hours, and the baking temperature is 50 ℃. The invention has the beneficial effects that: the Chinese medicinal composition has the main effects of clearing heat and removing toxicity, protecting the liver, moistening the lung, relieving cough and improving the immunity of a human body, resists the invasion of various inflammations and viral colds from the human body, overcomes the defect that western medicines are used for treating the colds, avoids damaging other internal organs, and has the advantages of convenient and safe use, small toxic or side effect and no adverse reaction. Prepared from a plurality of common herbal medicines, has low cost and quick response, can relieve and eliminate various symptoms of the viral influenza in about three days, and can quickly recover the patients to normal work and study.
Detailed Description
In order to more clearly illustrate the invention, the invention is further described below in connection with preferred embodiments. It is to be understood by persons skilled in the art that the following detailed description is illustrative and not restrictive, and is not to be taken as limiting the scope of the invention.
Example one
Weighing the following raw materials in proportion: 30 parts of galium aparine, 30 parts of plantain, 40 parts of cordate houttuynia, 20 parts of herba arthrodii, 30 parts of Chinese forest frog grass, 10 parts of liquorice, 30 parts of scutellaria baicalensis, 15 parts of almond, 20 parts of fritillaria cirrhosa, 20 parts of radix bupleuri, 20 parts of mint, 30 parts of dandelion and 25 parts of lalang grass rhizome.
A preparation method of powder comprises the following steps:
step one, cleaning raw materials: cleaning the above raw materials;
step two, drying and baking: putting the prepared raw materials in the first step into a far infrared oven for drying and baking, wherein the baking time is 6-7 hours, and the baking temperature is 50-60 ℃;
step three, crushing: crushing the raw materials baked and dried in the second step by using a crusher respectively;
step four, pulverizing: weighing the powder prepared in the third step according to the weight proportion, and putting the powder into a stirrer to be uniformly stirred;
step five, packaging and bagging: and (4) packaging the mixed powder stirred and blended in the step four into bags, wherein each packaging paper bag is thin kraft paper containing tin, the weight of each bag is 300-500 g, and an electric sealing machine is used for packaging.
Further, in the second step, the baking time was 6 hours and the baking temperature was 60 ℃.
Further, in the second step, the baking time was 7 hours and the baking temperature was 50 ℃.
Example two
Weighing the following raw materials in proportion: 23 parts of galium aparine, 25 parts of plantain, 30 parts of cordate houttuynia, 15 parts of arthroncus, 20 parts of Chinese forest frog grass, 7 parts of liquorice, 22 parts of scutellaria baicalensis, 11 parts of almond, 17 parts of fritillaria cirrhosa, 16 parts of radix bupleuri, 17 parts of mint, 26 parts of dandelion and 20 parts of lalang grass rhizome.
The preparation method is the same as the first embodiment.
EXAMPLE III
Weighing the following raw materials in proportion: 33 parts of galium aparine, 35 parts of plantain, 49 parts of cordate houttuynia, 23 parts of arthroncus, 33 parts of Chinese forest frog grass, 15 parts of liquorice, 35 parts of scutellaria baicalensis, 17 parts of almond, 23 parts of fritillaria cirrhosa, 23 parts of radix bupleuri, 25 parts of mint, 33 parts of dandelion and 30 parts of lalang grass rhizome.
The preparation method is the same as the first embodiment.
The invention adopts the galium aparine, the dandelion, the houttuynia cordata, the plantain, the scutellaria baicalensis and the toad grass which all have the effects of clearing away heat and toxic materials, resisting bacteria and diminishing inflammation, and particularly have good antiviral effect;
the essential oil has effects of dispelling pathogenic heat, relieving fever, relieving pain, tranquilizing, resisting virus, resisting inflammation, relieving convulsion, and resisting endogenous toxin activity;
licorice, almond, and Equisetum ramosissimum: has effects of clearing heat, removing toxic substances, eliminating phlegm, relieving cough, and moistening lung, wherein radix Glycyrrhizae also has effects of Chinese medicinal properties and antiallergic effect;
mint: has antiinflammatory, analgesic, and toxic materials clearing away effects, especially has effects of dispelling pathogenic wind and heat, and inducing perspiration;
cogongrass rhizome: has effects in cooling blood, stopping bleeding, clearing away heat and toxic materials, and protecting liver.
The eating method comprises the following steps: the powder is added into water with the weight 5-7 times of that of the powder for decoction, and the powder is directly drunk 10 minutes after the water is boiled.
Typical clinical cases
Case 1: when a woman in the Jiang lake farm, who is 49 years old in the year, in Tianmen of Hubei province, is just getting ill, the disease is warm, cough, sore throat, hypodynamia of the whole body and muscle ache, 300 g of the powder is added into 1500 g of water for decoction, the powder is drunk for three times in the morning, at noon and at night 10 minutes after the water is boiled, the cough is relieved on the day, various symptoms are relieved on the next day, and the powder is completely recovered on the third day.
Case 2: li Jian, a man, a Jiang lake farm in Tianmen of Hubei province, 38 years old, and when the disease is just happening, dry throat, sore throat, cough and myalgia are caused, 300 g of the powder is added into 1500 g of water for decoction, the powder is drunk in the morning, the noon and the evening for three times 10 minutes after the water is boiled, and the symptoms disappear after two days.
It is obvious that the above examples are only for illustrative clarity of the present invention and are not intended to limit the embodiments of the present invention, and that other variations or modifications may be made by those skilled in the art on the basis of the above description.
Claims (7)
1. The powder is characterized by comprising the following raw materials in parts by weight: 23-33 parts of galium aparine, 25-35 parts of plantain herb, 30-49 parts of houttuynia cordata, 15-23 parts of arthroncus, 20-33 parts of Chinese forest frog grass, 7-15 parts of liquorice, 22-35 parts of scutellaria baicalensis, 11-17 parts of almond, 17-23 parts of fritillaria cirrhosa, 16-23 parts of radix bupleuri, 17-25 parts of mint, 26-33 parts of dandelion and 20-30 parts of lalang grass rhizome.
2. The powder of claim 1, wherein the powder comprises 30 parts of Balsamiferou blumea herb, 30 parts of plantain herb, 40 parts of houttuynia cordata, 20 parts of Equisetum ramosissimum, 30 parts of Chinese forest frog herb, 10 parts of liquorice, 30 parts of Scutellaria baicalensis, 15 parts of almond, 20 parts of fritillaria cirrhosa, 20 parts of radix bupleuri, 20 parts of mint, 30 parts of dandelion and 25 parts of lalang grass rhizome.
3. The powder of claim 1, wherein the raw materials comprise 23 parts of Balsamiferou blumea herb, 25 parts of plantain herb, 30 parts of houttuynia cordata, 15 parts of Equisetum ramosissimum, 20 parts of Chinese forest frog herb, 7 parts of liquorice, 22 parts of Scutellaria baicalensis, 11 parts of almond, 17 parts of fritillaria cirrhosa, 16 parts of radix bupleuri, 17 parts of mint, 26 parts of dandelion and 20 parts of lalang grass rhizome.
4. The powder of claim 1, wherein the herbal materials comprise 33 parts of Balsamiferou blumea herb, 35 parts of plantain herb, 49 parts of houttuynia cordata, 23 parts of Equisetum ramosissimum, 33 parts of Chinese forest frog herb, 15 parts of licorice, 35 parts of Scutellaria baicalensis, 17 parts of almond, 23 parts of fritillaria cirrhosa, 23 parts of radix bupleuri, 25 parts of mint, 33 parts of dandelion and 30 parts of lalang grass rhizome.
5. A process for the preparation of a powder according to any one of claims 1 to 4, comprising the steps of:
step one, cleaning raw materials: cleaning the above raw materials;
step two, drying and baking: putting the prepared raw materials in the first step into a far infrared oven for drying and baking, wherein the baking time is 6-7 hours, and the baking temperature is 50-60 ℃;
step three, crushing: crushing the raw materials baked and dried in the second step by using a crusher respectively;
step four, pulverizing: weighing the powder prepared in the third step according to the weight proportion, and putting the powder into a stirrer to be uniformly stirred;
step five, packaging and bagging: and (4) packaging the mixed powder stirred and blended in the step four into bags, wherein each packaging paper bag is thin kraft paper containing tin, the weight of each bag is 300-500 g, and an electric sealing machine is used for packaging.
6. The preparation method according to claim 5, wherein in the second step, the baking time is 6 hours, and the baking temperature is 60 ℃.
7. The preparation method according to claim 5, wherein in the second step, the baking time is 7 hours, and the baking temperature is 50 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010239209.9A CN111249404A (en) | 2020-03-30 | 2020-03-30 | Powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010239209.9A CN111249404A (en) | 2020-03-30 | 2020-03-30 | Powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111249404A true CN111249404A (en) | 2020-06-09 |
Family
ID=70942232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010239209.9A Withdrawn CN111249404A (en) | 2020-03-30 | 2020-03-30 | Powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111249404A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112089798A (en) * | 2020-10-27 | 2020-12-18 | 李群营 | Traditional Chinese medicine composition for treating rabies as well as preparation method and application thereof |
CN117158444A (en) * | 2023-09-05 | 2023-12-05 | 通化康元生物科技有限公司 | A wood frog antibacterial peptide preparation, its preparation method and application in external protection product and anti-influenza virus medicine |
-
2020
- 2020-03-30 CN CN202010239209.9A patent/CN111249404A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112089798A (en) * | 2020-10-27 | 2020-12-18 | 李群营 | Traditional Chinese medicine composition for treating rabies as well as preparation method and application thereof |
CN117158444A (en) * | 2023-09-05 | 2023-12-05 | 通化康元生物科技有限公司 | A wood frog antibacterial peptide preparation, its preparation method and application in external protection product and anti-influenza virus medicine |
CN117158444B (en) * | 2023-09-05 | 2024-02-27 | 通化康元生物科技有限公司 | A wood frog antibacterial peptide preparation, its preparation method and application in external protection product and anti-influenza virus medicine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103505656B (en) | Chinese medicine preparation for treating stomatitis | |
CN111249404A (en) | Powder and preparation method thereof | |
EP3821902A1 (en) | Traditional chinese medicine composition, traditional chinese medicine compound preparation and preparation method and use thereof | |
CN101829278B (en) | Quick antiphlogistic and analgesic Chinese herbal preparation | |
CN104288521A (en) | Traditional Chinese medicinal composition for treating diarrhea and preparation method and application thereof | |
CN105396017A (en) | Traditional Chinese medicine preparation used for treating fatty liver, and preparation method thereof | |
CN105381291A (en) | Traditional Chinese medicine composition for preventing and treating pneumonia, preparation method and applications thereof | |
CN105748685B (en) | Beriberi bacteriostat and preparation method thereof | |
CN100438904C (en) | A Chinese medicinal composition for clearing away heat and toxic materials, and preventing and treating common cold, and its preparation method | |
CN104189663A (en) | Liver-soothing depression-relieving preparation for cervical tuberculous lymphadenitis and preparation method | |
CN103536851A (en) | Traditional Chinese medicine composition for treating alcoholic fatty liver | |
CN103721028B (en) | One treats anginal medicine and preparation method | |
CN103263614A (en) | Pharmaceutical composition for preventing or treating vaginitis | |
CN102327440A (en) | Chinese herbal medicine for treating deep multiple abscess | |
CN100364567C (en) | Oral liquid for cold | |
CN1970044A (en) | Medicinal composition for treating rheumatoid arthritis and method for preparing same | |
CN101259165A (en) | Chaihuang preparations and producing method thereof | |
CN106266297A (en) | A kind of medicine treating laryngopharynx swelling and pain | |
CN105030936A (en) | Chinese medicine for treating keratoconjunctivitis | |
CN104887823A (en) | Traditional Chinese medicine composition for treating nasopharyngeal carcinoma and administration method thereof | |
CN104984231A (en) | Traditional Chinese medicine for treating malaria | |
CN105106509A (en) | Traditional Chinese medicine oral liquid for treating oral leukoplakia | |
CN102688406B (en) | Houttuynia cordata traditional Chinese medicine decoction for treating cough and preparation method | |
CN103768314A (en) | Traditional Chinese medicinal composition for treating chikungunya fever and preparation method thereof | |
CN102293902B (en) | Black factice for treating snake bite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200609 |
|
WW01 | Invention patent application withdrawn after publication |